Results 1 to 10 of about 12,469 (206)

Progressive multifocal leukoencephalopathy [PDF]

Current Neurology and Neuroscience Reports, 2008
Progressive multifocal leukoencephalopathy is a demyelinating disease of the central nervous system caused by the reactivation of latent JC virus.
Joseph R Berger, Berger Joseph R
exaly   +9 more sources

Progressive Multifocal Leukoencephalopathy in an Immunocompetent Patient [PDF]

Case Reports in Neurology, 2013
Background: Progressive multifocal leukoencephalopathy (PML) is a rapidly progressive, potentially fatal, demyelinating disease affecting immunosuppressed patients.
Krisztina K. Johansen, Sverre H. Torp, Jana Rydland, Jan O. Aasly   +3 more
doaj   +6 more sources

Progressive Multifocal Leukoencephalopathy [PDF]

Neurologic Clinics, 2018
Progressive multifocal leukoencephalopathy (PML) is a rare opportunistic infection that occurs in patients whose immune system is compromised either because of an underlying illness or an immunosuppressive medication. John Cunningham virus, prevalent in 60% or more of the adult population as a latent or persistent infection, is responsible for the ...
Elena Grebenciucova, Joseph R Berger
exaly   +9 more sources

Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab

Emerging Infectious Diseases, 2018
Progressive multifocal leukoencephalopathy (PML) is increasingly being reported in patients undergoing immunotherapy. We report a case of progressive multifocal leukoencephalopathy after treatment with nivolumab, a PD-1 blocker that is used to restore ...
Martin Martinot, Guido Ahle, Inesa Petrosyan, Camille Martinez, Dragos M. Gorun, Mahsa Mohseni-Zadeh, Samira Fafi-Kremer, Martine Tebacher-Alt   +7 more
doaj   +2 more sources

Atezolizumab Treatment for Progressive Multifocal Leukoencephalopathy

Emerging Infectious Diseases, 2022
Atezolizumab successfully reinvigorated JC virus immunity in a patient in Belgium with progressive multifocal leukoencephalopathy, as demonstrated by clinical, virologic, and radiologic response to treatment.
Nicolas Lambert, Solène Dauby, Dominique Dive, Bernard Sadzot, Pierre Maquet   +4 more
doaj   +2 more sources

Asymptomatic progressive multifocal leukoencephalopathy: a case report and review of the literature

Journal of Medical Case Reports, 2018
Background We report the development of asymptomatic progressive multifocal leukoencephalopathy in a patient with multiple sclerosis on natalizumab therapy.
Yinan Zhang, Crystal Wright, Angela Flores   +2 more
doaj   +2 more sources

Treatment of progressive multifocal leukoencephalopathy [PDF]

Journal of Neurology, 2019
Progressive multifocal leukoencephalopathy (PML) is a rapidly progressive demyelinating disease of the central nervous system caused by John Cunningham polyomavirus (JCV), a globally seroprevelant virus that commonly causes a silent or benign infection. However, in immunocompromised patients JCV can be reactivated. In this situation, most organs remain
Castle, Daniel, Robertson, Neil P.
openaire   +4 more sources

Progressive multifocal leukoencephalopathy in rheumatoid arthritis and biological therapies: a case report and review of the literature [PDF]

Journal of Medical Case Reports
Background Progressive multifocal leukoencephalopathy is a rare but potentially fatal disease caused by infection of the central nervous system with John Cunningham polyomavirus.
Barbara Bergmans, Gerwin Roks, Eugène van Puijenbroek, Esther de Vries, Jean-Luc Murk   +4 more
doaj   +3 more sources

Progressive Multifocal Leukoencephalopathy in an AIDS Patient

Journal of the Formosan Medical Association, 2007
Progressive multifocal leukoencephalopathy (PML) is a demyelinating brain disease caused by Jamestown Canyon virus (JCV). This disease is an important cause of morbidity and mortality in acquired immunodeficiency syndrome (AIDS) patients.
Ming-Hsing Lee, Yan-Zhong Chen, Yung-Hsiang Hsu   +2 more
doaj   +3 more sources

Progressive multifocal leukoencephalopathy developing in a fludarabine naïve patient with chronic lymphocytic leukemia

International Journal of General Medicine, 2009
Melissa G Ooi1, Peter J Kelly2, Michael Farrell3, Philip Murphy4, Peter O’Gorman11Department of Hematology; 2Department of Neurology, Mater Misericordiae Hospital, Dublin, Ireland; 3Department of Neuropathology; 4Department of Hematology ...
Melissa G Ooi, Peter J Kelly, Michael Farrell, Philip Murphy, Peter O’Gorman   +4 more
doaj   +1 more source